RESULTS	There was no difference between the AZA - and MTX-groups in respect of prednisone dosing ( apart from months 10 and 12 ) , in quantitative MG Score improvement , proportions in sustained remission , frequencies of MG relapses , or adverse reactions and/or withdrawals .\